The Ventral Medulla and the Sudden Infant Death Syndrome
The Ventral Medulla and the Sudden Infant Death Syndrome
批准号:
7869627
负责人:
Hannah Chase Kinney
金额:
$7.0万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2013-03-31
关键词:
AcetylcholineAgeAirAlcoholsAminobutyric AcidsAnimal ModelAnimalsArousalAsphyxiaBack to SleepBrain StemCardiacCategoriesCell CountCell Culture TechniquesCellsCessation of lifeChemosensitizationChronicComplementDataDefectDevelopmentDiseaseDorsalExhalationExperimental ModelsExposure toFemaleFigs - dietaryFunctional disorderGenderGenetically Engineered MouseGoalsHomeostasisHumanHypercapniaHypoxiaInfantInfant MortalityLeadLifeMediatingMedulla OblongataMindModelingMolecularMusNeuromodulatorNeuronsNewborn InfantNorepinephrinePathogenesisPathologyPhysiologicalPopulationPositioning AttributePregnancyPreparationReflex actionRegulationResearchRespiratory physiologyRiskRisk FactorsRodent ModelRoleSerotoninShapesSleepSliceSubstance PSudden DeathSudden infant death syndromeSystemTestingTimeUnited Statesanimal tissuebasecritical perioddevelopmental diseasegamma-Aminobutyric Acidhypocretininfant deathinterdisciplinary approachmalematernal cigarette smokingmedullary serotonergic systemmodel developmentmouse modelneurochemistryneuroepitheliumneuromechanismneuropathologypostnatalprenatal exposureprogenitorprogramsreceptor bindingrelating to nervous systemrespiratoryresponseserotonin receptorsleep positionstressorsuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Despite the success of the Back-to-Sleep campaign, the sudden infant death syndrome (SIDS) remains the
leading cause of postneonatal infant mortality in the United States today. The major discovery of this
program project in the last cycle was that multiple developmental abnormalities in the medullary
serotonergic (5-HT) system are associated with SIDS. These human findings in Project 1 have lead to the
establishment of a critical role for the medullary 5-HT system in the state-related regulation of multiple
homeostatic functions in animal models in Projects 2-4. Additionally, they have lead to establishment of the
developmental profile at the molecular level of the brainstem 5-HT system in Project 5. These discoveries
have lead to the following over-riding hypothesis for the proposed third cycle: an important subset
of SIDS is due to a developmental disorder of the medullary 5-HT system and related
neuromodulator systems that are incurred prenatally, but which exerts its effects postnatally¿
during the first 6 months of life when the newborn, in transitioning to extrauterine life, undergoes
maturation of circuitry for maintaining independent homeostasis and is at the greatest risk for SIDS.
This disorder impairs protective homeostatic responses to potentially life-threatening, but often occurring,
stressors during infant sleep that lead in turn to homeostatic derangements (hypoxia, hypercarbia), each
potentially non-lethal in themselves, but which in combination precipitate death. Our objectives are: 1) To
define the role of multiple transmitters/modulators in the neurochemical medullary pathology in SIDS infants;
2) To determine in rodent models the effect of homeostatic stressors¿alone and in combination¿upon
autonomic and respiratory function during different sleep states, in males and females, and at different
ages; 3) To determine the role of chronic intermittent hypoxia in the potentiation of the brainstem pathology
in SIDS; 4) To determine the role of y-aminobutyric acid (GABA), orexin, substance P, norepinephrine, and
acetylcholine in interacting with the medullary 5-HT system in homeostatic regulation in animal models; 5)
To establish the organization and connectivity of the medullary 5-HT system¿the "integrator" of diverse
homeostatic functions mediated by multiple effector neurons; 6) To inhibit ("silence") molecularly defined
subsets of 5-HT and GABA neurons and determine the physiological consequences in the living mouse. In
the proposed third cycle, we will test the over-riding hypothesis utilizing a multidisciplinary
approach in which human, animal, tissue slice, cell culture, and developmental data are integrated
together, thereby informing and expanding upon each other towards establishing the pathogenesis
of SIDS from the cellular to systems level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Ventral Medulla and the Sudden Infant Death Syndrome
-
批准号:7931841
-
项目类别:
-
资助金额:$13.21万
-
财政年份:2009
-
负责人:Hannah Chase Kinney
-
依托单位:
Prenatal Alcohol in Sudden Infant Death Syndrome and Stillbirth (PASS) Network
-
批准号:7666401
-
项目类别:
-
资助金额:$9.46万
-
财政年份:2003
-
负责人:Hannah Chase Kinney
-
依托单位:
Prenatal Alcohol in Sudden Infant Death Syndrome and Stillbirth (PASS) Network
-
批准号:7678562
-
项目类别:
-
资助金额:$68.87万
-
财政年份:2003
-
负责人:Hannah Chase Kinney
-
依托单位:
Prenatal Alcohol in Sudden Infant Death Syndrome and Stillbirth (PASS) Network
-
批准号:7503971
-
项目类别:
-
资助金额:$58.16万
-
财政年份:2003
-
负责人:Hannah Chase Kinney
-
依托单位:
Prenatal Alcohol in Sudden Infant Death Syndrome and Stillbirth (PASS) Network
-
批准号:8535560
-
项目类别:
-
资助金额:$71.81万
-
财政年份:2003
-
负责人:Hannah Chase Kinney
-
依托单位:
Prenatal Alcohol in Sudden Infant Death Syndrome and Stillbirth (PASS) Network
-
批准号:7924782
-
项目类别:
-
资助金额:$61.48万
-
财政年份:2003
-
负责人:Hannah Chase Kinney
-
依托单位:
Prenatal Alcohol in Sudden Infant Death Syndrome and Stillbirth (PASS) Network
-
批准号:8203716
-
项目类别:
-
资助金额:$73.91万
-
财政年份:2003
-
负责人:Hannah Chase Kinney
-
依托单位:
Prenatal Alcohol in Sudden Infant Death Syndrome and Stillbirth (PASS) Network
-
批准号:8336747
-
项目类别:
-
资助金额:$74.18万
-
财政年份:2003
-
负责人:Hannah Chase Kinney
-
依托单位:
The Ventral Medulla and the Sudden Infant Death Syndrome
-
批准号:8607742
-
项目类别:
-
资助金额:$167.37万
-
财政年份:1998
-
负责人:Hannah Chase Kinney
-
依托单位:
The Ventral Medulla and the Sudden Infant Death Syndrome
-
批准号:7439725
-
项目类别:
-
资助金额:$205.78万
-
财政年份:1998
-
负责人:Hannah Chase Kinney
-
依托单位:
The Ventral Medulla and the Sudden Infant Death Syndrome
-
批准号:8063494
-
项目类别:
-
资助金额:$201.69万
-
财政年份:1998
-
负责人:Hannah Chase Kinney
-
依托单位:
The Ventral Medulla and the Sudden Infant Death Syndrome
-
批准号:8282992
-
项目类别:
-
资助金额:$202.64万
-
财政年份:1998
-
负责人:Hannah Chase Kinney
-
依托单位:
The Ventral Medulla and the Sudden Infant Death Syndrome
-
批准号:7615666
-
项目类别:
-
资助金额:$199.74万
-
财政年份:1998
-
负责人:Hannah Chase Kinney
-
依托单位:
The Ventral Medulla and the Sudden Infant Death Syndrome
-
批准号:7799849
-
项目类别:
-
资助金额:$203.73万
-
财政年份:1998
-
负责人:Hannah Chase Kinney
-
依托单位:
Brainstem Maturation in the Sudden Infant Death Syndrome
-
批准号:8040662
-
项目类别:
-
资助金额:$65.92万
-
财政年份:1992
-
负责人:Hannah Chase Kinney
-
依托单位:
Brainstem Maturation in the Sudden Infant Death Syndrome
-
批准号:8233928
-
项目类别:
-
资助金额:$66.01万
-
财政年份:1992
-
负责人:Hannah Chase Kinney
-
依托单位:
Brainstem Maturation in the Sudden Infant Death Syndrome
-
批准号:8446413
-
项目类别:
-
资助金额:$64.11万
-
财政年份:1992
-
负责人:Hannah Chase Kinney
-
依托单位:
BRAINSTEM MATURATION IN THE SUDDEN INFANT DEATH SYNDROME
-
批准号:7414594
-
项目类别:
-
资助金额:$31.41万
-
财政年份:1992
-
负责人:Hannah Chase Kinney
-
依托单位:
BRAINSTEM MATURATION IN THE SUDDEN INFANT DEATH SYNDROME
-
批准号:8066828
-
项目类别:
-
资助金额:$15.51万
-
财政年份:1992
-
负责人:Hannah Chase Kinney
-
依托单位:
NEUROCHEMICAL PATHOLOGY IN SIDS BRAINSTEMS
-
批准号:8282984
-
项目类别:
-
资助金额:$20.85万
-
财政年份:--
-
负责人:Hannah Chase Kinney
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: